93 7540 (Topiramate 50 mg)

Pill imprint 93 7540 has been identified as Topiramate 50 mg.

Topiramate is used in the treatment of obesity; bipolar disorder; fibromyalgia; migraine prevention; vulvodynia (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 50 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 93 7540

Topiramate 50 mg 93 7540
Topiramate 50 mg 93 7540
Topiramate 50 mg 93 7540
Topiramate
Imprint:
93
7540
Strength:
50 mg
Color:
Yellow
Size:
11.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-7540
Inactive Ingredients:
silicon dioxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol
corn starch
titanium dioxide
ferric oxide yellow
polyvinyl alcohol
magnesium silicate

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)